Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor–Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
Leisha A. Emens(Johns Hopkins University), Elizabeth M. Jaffee(Bloomberg (United States)), J A Levi(Johns Hopkins University), John H. Fetting(Johns Hopkins University), Justin M. Asquith(Johns Hopkins University), Antonio C. Wolff(Johns Hopkins University), Barry Kobrin(Johns Hopkins University), Mary L. Disis(University of Washington), Nancy E. Davidson(WinnMed), Marina Laiko(Johns Hopkins University), Vered Stearns(Johns Hopkins University), James M. Leatherman(Geisinger Medical Center), S. Petrik(Johns Hopkins University), Steven Piantadosi(Brigham and Women's Hospital), Xiaobu Ye(Johns Hopkins University), Maithili M. Daphtary(Johns Hopkins University), Barbara Biedrzycki(Johns Hopkins University)
Cited by 234
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
|Journal of Clinical Oncology|2010|4.3k
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
|Science|2008|4k
AACR Project GENIE: Powering Precision Medicine through an International Consortium
|Cancer Discovery|2017|2k